Bhattacharyya Swati, Cowan Morton J
Bone Marrow Transplant Division, Department of Pediatrics, University of California San Francisco Children's Hospital, CA 94143-1278, USA.
Biol Blood Marrow Transplant. 2005 Sep;11(9):657-71. doi: 10.1016/j.bbmt.2005.05.012.
In utero hematopoietic stem cell transplantation (IUT) results in limited chimerism and tolerance to alloantigens. We studied the relative role of B7.1 and B7.2 expression by dendritic cells (DCs) in engraftment and in generating donor-specific tolerance in fetal mice. Mature dendritic cells (mDCs) from B7.1(-/-) or B7.2(-/-) donors and wild-type (WT) lineage-depleted (lin(-)) C57BL/6 (B6) bone marrow (BM) were injected into BALB/c fetuses. Six weeks after IUT, B7.1(-/-) recipients had multilineage engraftment (4.7% +/- 0.8% T cells and 5.7% +/- 1.1% granulocytes) associated with graft-versus-host disease (GVHD) and decreased survival, but by 12 weeks only donor CD3(+) cells (2.1% +/- 1.3%) were present. Recipients of B7.2(-/-) mDCs and lin(-) WT B6 BM had exclusively CD3(+)CD4(+) T cells (11.8% +/- 8.5% at 6 weeks and 6.5% +/- 2.5% at 12 weeks). Most of the cells were T-helper 2, although 10.4% +/- 1.4% were of the T-regulatory (T(reg)) phenotype, ie, CD4(+)CD25(+). Donor T(reg) cells were detected both in the thymus and spleen, thus suggesting an effect on both central and peripheral immunity. The animals with T(reg) cells had better survival (82.3% versus 47.4%; P < .01) and no GVHD (0% versus 65%; P < .001). This group alone demonstrated multilineage engraftment of donor hematopoietic cells after postnatal transplantation with megadoses of donor lin(-) BM. Both the engrafted donor CD4(+)CD25(-) and CD4(+)CD25(+) cells induced comparable in vitro suppression of T-cell proliferation, thus suggesting their role in the persistence of the donor T cells in vivo. The CD4(+)CD25(-) cells produced interleukin 10 or interleukin 4 and were inhibited by anti-T-helper 2 cytokine-neutralizing antibodies, whereas the CD4(+)CD25(+) cells showed no evidence of any involvement of a cytokine-like soluble mediator and expressed cytotoxic T-lymphocyte antigen 4 (CTLA-4) and foxp3 constitutively. Donor mDCs and donor CD4 T cells were detected among the thymocytes of the recipients of B7.2(-/-) mDCs and lin(-) WT B6 BM. Thus, it seems that costimulatory molecule expression of donor DCs can play a significant immunomodulatory role in survival, GVHD, engraftment, and homing of allogeneic BM cells after IUT through the generation of T(reg) cells.
子宫内造血干细胞移植(IUT)导致嵌合率有限且对同种异体抗原产生耐受性。我们研究了树突状细胞(DC)表达的B7.1和B7.2在胎鼠植入及产生供体特异性耐受性中的相对作用。将来自B7.1(-/-)或B7.2(-/-)供体的成熟树突状细胞(mDC)和野生型(WT)谱系清除(lin(-))C57BL/6(B6)骨髓(BM)注入BALB/c胎儿体内。IUT后6周,B7.1(-/-)受体出现多谱系植入(4.7%±0.8%的T细胞和5.7%±1.1%的粒细胞),伴有移植物抗宿主病(GVHD)且存活率降低,但到12周时仅存在供体CD3(+)细胞(2.1%±1.3%)。接受B7.2(-/-)mDC和lin(-)WT B6 BM的受体仅存在CD3(+)CD4(+)T细胞(6周时为11.8%±8.5%,12周时为6.5%±2.5%)。大多数细胞为辅助性T细胞2型,尽管10.4%±1.4%为调节性T(Treg)表型,即CD4(+)CD25(+)。在胸腺和脾脏中均检测到供体Treg细胞,这表明其对中枢和外周免疫均有影响。具有Treg细胞的动物存活率更高(82.3%对47.4%;P<.01)且无GVHD(0%对65%;P<.001)。仅该组在出生后用大剂量供体lin(-)BM移植后显示出供体造血细胞的多谱系植入。植入的供体CD4(+)CD25(-)和CD4(+)CD25(+)细胞在体外对T细胞增殖的抑制作用相当,这表明它们在体内供体T细胞持续存在中发挥作用。CD4(+)CD25(-)细胞产生白细胞介素10或白细胞介素4,并被抗辅助性T细胞2细胞因子中和抗体抑制,而CD4(+)CD25(+)细胞未显示有任何细胞因子样可溶性介质参与的证据,并持续表达细胞毒性T淋巴细胞抗原4(CTLA-4)和叉头框蛋白3(foxp3)。在接受B7.2(-/-)mDC和lin(-)WT B6 BM的受体的胸腺细胞中检测到供体mDC和供体CD4 T细胞。因此,似乎供体DC的共刺激分子表达可通过产生Treg细胞在IUT后同种异体BM细胞的存活、GVHD、植入和归巢中发挥重要的免疫调节作用。